|
DYN Dyne Therapeutics, Inc 1818794 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-178,556,000.00 |
| Balance Sheet |
|
Current Assets
|
$937,889,000.00 |
|
Assets
|
$994,013,000.00 |
|
Current Liabilities
|
$78,029,000.00 |
|
Liabilities
|
$291,862,000.00 |
|
Equity
|
$702,151,000.00 |
|
Shares Out
|
165670880.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-275,208,000.00 |
|
Investing Cash Flow
|
$-7,187,000.00 |
| Market Analysis |
Market Cap
|
$2,667,301,168.00 |
|
Price
|
$16.82 |
|
BVPS
|
4.24 |
|
PB
|
3.80 |
|
EPS
|
-1.08 |
|
FCF
|
$-276,943,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-10-01 09:31:20 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-10-26 10:00:15 |
|
| Apr |
May |
Jun |
| 2026-03-02 |
-0.76 |
|
|
2026-05-11 |
-0.73 |
|
| Jul |
Aug |
Sep |
|
|
2025-07-28 |
-0.97 |
|
|
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.76 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DYN documents filed with the SEC.
DYN Filings
Clear
